Skip to main content
Journal of Community Genetics logoLink to Journal of Community Genetics
. 2012 Feb 4;3(4):319–322. doi: 10.1007/s12687-012-0081-5

Allelic clustering and ancestry-dependent frequencies of rs6232, rs6234, and rs6235 PCSK1 SNPs in a Northern Ontario population sample

Francine Sirois 1, Nadine Kaefer 1, Krista A Currie 3, Michel Chrétien 1,2, Kabwe K Nkongolo 3, Majambu Mbikay 1,2,
PMCID: PMC3461222  PMID: 22307923

Abstract

The PCSK1 (proprotein convertase subtilisin/kexin type 1) locus encodes proprotein convertase 1/3, an endoprotease that converts prohormones and proneuropeptides to their active forms. Spontaneous loss-of-function mutations in the coding sequence of its gene have been linked to obesity in humans. Minor alleles of two common non-synonymous single-nucleotide polymorphisms (SNPs), rs6232 (T > C, N221D) and rs6235 (C > G, S690T), have been associated with increased risk of obesity in European populations. In this study, we compared the frequencies of the rs6232 and rs6234 (G > C, Q665E) SNPs in Aboriginal and Caucasian populations of Northern Ontario. The two SNPs were all relatively less frequent in Aboriginals: The minor allele frequency of the rs6232 SNP was 0.01 in Aboriginals and 0.08 in Caucasians (P < 4.10−6); for the rs6234 SNP, it was 0.20 and 0.32, respectively (P < 0.001). Resequencing revealed that the rs6234 SNP variation was tightly linked to that of the rs6235 SNP, as previously reported. Most interestingly, all carriers of the rs6232 SNP variation also carried the rs6234/rs6235 SNP clustered variations, but not the reverse, suggesting the former occurred later on an allele already carrying the latter. These data indicate that, in Northern Ontario Aboriginals, the triple-variant PCSK1 allele is relatively rare and might be of lesser significance for obesity risk in this population.

Electronic supplementary material

The online version of this article (doi:10.1007/s12687-012-0081-5) contains supplementary material, which is available to authorized users.

Keywords: Proprotein convertase, Obesity, Genetic polymorphism, Population genetics, Aboriginals, Caucasians

Introduction

Proprotein convertase 1/3 (PC1/3) is a serine endoprotease involved in the proteolytic activation of prohormones and proneuropeptides in the secretory pathway of endocrine and neuroendocrine cells (Seidah and Chretien 1999). It is the product of the 14-exon PCSK1 (proprotein convertase subtilisin/kexin-type 1) gene mapping on human chromosome 5. It is biosynthesized in the endoplasmic reticulum as a secretory zymogen which gets activated in downstream secretory compartments by successive autocatalytic removal of segments at the amino and at the carboxyl termini (Muller and Lindberg 1999).

PC1/3 is highly expressed in hypothalamic nuclei that controls appetite (Dong et al. 1997). Its substrates in the brain and the periphery include precursors of hormones and neuropeptides that regulate feeding and food processing. Induced PC1/3 genetic deficiency in mouse causes greater body weight gain (Zhu et al. 2002; Lloyd et al. 2006; Mbikay et al. 2007). Spontaneous non-synonymous mutations in its sequence have been linked to obesity in humans (Jackson et al. 1997, 2003; Farooqi et al. 2007). In a case–control association study in populations of European ancestry, Benzinou et al. (2008) were the first to show that three common non-synonymous single-nucleotide polymorphisms (SNPs) in the PCSK1 locus are strongly linked to risk of obesity. Because Aboriginal populations of Canada are disproportionably burdened by obesity (Liu et al. 2006), we sought to determine the frequencies of these SNPs in a sample population of Aboriginal Canadians from Northern Ontario.

Subjects

This study was conducted with archival blood samples. These samples were collected to determine the frequency and distribution of genetic variations in Northern Ontario Aboriginals and Caucasians (Currie et al. 2005). Ancestry was the only information asked of participants. Unrelated subjects were recruited at three Northern Ontario regional hospitals located in Espanola (100 Aboriginals, 100 Caucasians), Sioux Lookout (100 Aboriginals), and Wikwemikong (100 Aboriginals) (Currie et al. 2005). Aboriginal participants were predominantly of the Cree-Ojibwa groups. The recruitment was conducted under a protocol approved by the Human Research Ethics Board of each hospital. Participants were explained the nature of the study and were asked for their informed consent and a blood sample. All samples were anonymized.

Methods

Genotyping of the rs6232 (T > C) SNP was conducted on the MX 3005P thermocycler (Stratagene, La Jolla, CA) using a Taqman assay based on the presence or absence of fluorescence due to degradation of allele-specific fluorochrome-conjugated probes as previously described (Sirois et al. 2008). Genotyping of the rs6234 (G > C) SNP was based on polymerase chain reaction (PCR) and melting curve analysis of differential fluorescence loss during heat-induced dehybridization of the probes from the SNP-containing region of genomic amplicon (Didenko 2001). It was conducted on a LightCycler instrument (Roche, Laval, QC).

Results and discussion

The nonsynonymous rs6234 and rs6235 SNPs are located in exon 14; they consist of G > C and C > G transversions and cause Q665E and S690T amino acid substitutions, respectively (Benzinou et al. 2008). Genomic PCR amplicons of this exon were produced using lymphocyte DNA from 50 Espanola participants, 25 Caucasians, and 25 Aboriginals; the DNA amplicons was sequenced (see Electronic supplementary material and Methods online). Twelve of the 50 participants were double heterozygotes for both the rs6234 and the rs6235 SNPs, confirming the tight linkage between these two SNPs (Benzinou et al. 2008).

The rs6234 SNP (G > C) was genotyped in all 400 DNA samples. There was 100% concordance between the genotyping results and those of resequencing for the 50 Espanola samples. Overall, the minor allele frequency (MAF) for this SNP in Aboriginals and Caucasians was 0.20 and 0.32, respectively (P < 0.001 by Fisher’s exact test). The G/G, G/C, and C/C genotype frequencies were respectively 0.62, 0.32, and 0.04 in Aboriginals and 0.43, 0.50, and 0.07 in Caucasians (Table 1).

Table 1.

Genotype and allele frequencies for the non-synonymous PCSK1 rs6234 (G > C, Q665E) SNP

Ethnicity Site Genotype frequencies Allele frequencies
G/G G/C C/C Total count G C Total count
Freq Count Freq Count Freq Count Freq Count Freq Count
Aboriginals Espanola 0.68 68 0.28 28 0.04 4 100 0.82 164 0.18 36 200
Sioux Lookout 0.63 63 0.34 34 0.03 3 100 0.80 160 0.20 40 200
Wikweminkong 0.62 62 0.33 33 0.05 5 100 0.785 157 0.215 43 200
All 0.643 193 0.317 95 0.04 12 300 0.802 481 0.198 119* 600
Caucasians Espanola 0.43 43 0.50 50 0.07 7 100 0.68 136 0.32 64 200

Freq frequency

*P < 0.001 relative to Espanola Caucasians by Fisher’s exact test

The rs6232 SNP (T > C) was also genotyped; the MAF was 0.01 in Aboriginals and 0.08 in Caucasians (P = 4.10−6) (Table 2). The T/T, T/C, and CC genotype frequencies were respectively 0.98, 0.02, and 0.00 in Aboriginals and 0.85, 0.14, and 0.01 in Caucasians. Interestingly, all carriers of the rs6232 variation also carried the rs6234/rs6235 variation cluster, but not the reverse, suggesting that the former occurred after the latter on the same PCSK1 allele. The linkage remains to be confirmed by sequencing. The genotype frequencies associated with the rs6232 and rs6234 SNPs in the two Northern Ontario populations were consistent with Hardy–Weinberg equilibrium (P > 0.05), excluding the possibility of a significant bias due to subject sampling, genotyping, or population dynamics. Through mechanisms yet to be elucidated, SNPs tend to cluster, and these clusters are non-randomly distributed in the human genome (Amos 2009). Our study is the first to demonstrate allelic clustering of the three non-synonymous PCSK1 variations.

Table 2.

Genotype and allele frequencies for non-synonymous PCSK1 rs6232 (T > C, N221D) SNP

Ethnicity Site Genotype frequencies Allele frequencies
T/T T/C C/C Total count T C Total count
Freq Count Freq Count Freq Count Freq Count Freq Count
Aboriginals Espanola 0.97 97 0.03 3 0 0 100 0.985 197 0.015 3 200
Sioux Lookout 0.99 99 0.01 1 0 0 100 0.995 199 0.005 1 200
Wikweminkong 0.98 98 0.02 2 0 0 100 0.99 198 0.010 2 200
All 0.98 294 0.02 6 0 0 300 0.98 594 0.01 6* 600
Caucasians Espanola 0.853 81 0.137 13 0.01 1 95 0.921 175 0.079 15 190

Freq frequency

*P = 4.10−6 relative to Espanola Caucasians by Fisher’s exact test

We have determined that the triple-variant zymogen specified by this allele undergoes post-translational proteolytic processing at its termini more efficiently than the common and the double-variant forms, when expressed ex vivo in a pituitary cell line. We have speculated that this accelerated processing might render this isoform unstable, causing a functional deficit of PC1/3 enzymatic activity (Mbikay et al. 2011).

Collectively, our data indicate that, in Northern Ontario, the rs6232, rs6234, and rs6235 SNPs are more frequent in Caucasians than in Aboriginals. MAFs for the rs6232 (0.08) and rs6235 (0.35) SNPs appear on average to be higher in Espanola Caucasians than those recently reported for various European population samples (0.052 to 0.064 and 0.22 to 0.47, respectively) (Benzinou et al. 2008; Goossens et al. 2009; Kilpelainen et al. 2009; Willer et al. 2009; Heni et al. 2010; Gjesing et al. 2011; Rouskas et al. 2011) (see also Electronic supplementary material Table S1). The sample size in the latter studies was far larger than that one used in our study, giving greater statistical power to their MAF determinations. The DNA panel of this study was previously used to determine the allele frequencies at the highly polymorphic D18S535 short tandem-repeat locus. These frequencies differed not only between Aboriginal and Espanola Caucasians but also between the latter and European Caucasians (Currie et al. 2005). Historical immigration records indicate Northern Ontario Caucasians were predominantly of French and British origins. It is likely that the higher MAFs of PCSK1 SNPs obtained with our limited sample of Northern Ontario Caucasians are due to genetic drift (e.g., founder effect) or adaptive evolution.

An association of the minor allele of rs6232 SNP with obesity parameters (body mass index, waist circumference, or waist–hip ratio) has been observed in three separate studies of European populations (Benzinou et al. 2008; Kilpelainen et al. 2009; Willer et al. 2009; Gjesing et al. 2011), but not two others (Heni et al. 2010; Rouskas et al. 2011). For the minor allele of rs6234 or rs6235 SNP, it was observed in three studies (Benzinou et al. 2008; Gjesing et al. 2011; Rouskas et al. 2011), but not in two others (Kilpelainen et al. 2009; Renstrom et al. 2009). In Han Chinese, the rs6234 SNP was associated with a combined phenotype of obesity and overweight in men, but not in women (Qi et al. 2010). In a study by Heni et al. (2010) of a German population sample, neither the rs6232 nor the rs6235 SNP minor allele was associated with weight-related traits; but they were both associated with impaired proinsulin processing and, for the rs6232 SNP, with insulin sensitivity. Interactions of these minor alleles with glucose homeostasis and incretin metabolism were also observed in a Danish population (Gjesing et al. 2011).

The relatively lower frequencies of these SNPs in Aboriginals calls for a systematic resequencing of the PCSK1 locus to determine whether there are other common genetic variations that might affect body mass and glucose homeostasis in this population. This call is also applicable for sub-Saharan Africans as our and online genotyping data suggest that the SNPs examined in this study are even rarer in this population (Electronic supplementary material Table S1).

Electronic supplementary material

ESM 1 (27.5KB, doc)

(DOC 27 kb)

ESM 2 (99KB, doc)

(DOC 99 kb)

Acknowledgments

This study was supported by grants from the Canadian Institutes of Health Research and from the Strauss Foundation.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Amos W. Even small SNP clusters are non-randomly distributed: is this evidence of mutational non-independence? Proc R Soc B. 2009;277:1443–1449. doi: 10.1098/rspb.2009.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benzinou M, Creemers JW, Choquet H, et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet. 2008;40:943–945. doi: 10.1038/ng.177. [DOI] [PubMed] [Google Scholar]
  3. Currie KA, Michael P, Nkongolo KK. Characterization of the D18S535 STR locus in northern Ontario European and Aboriginal populations for forensic purposes. Hum Biol. 2005;77:267–279. doi: 10.1353/hub.2005.0038. [DOI] [PubMed] [Google Scholar]
  4. Didenko VV (2001) DNA probes using fluorescence resonance energy transfer (FRET): designs and applications. Biotechniques 31:1106–1121 [DOI] [PMC free article] [PubMed]
  5. Dong W, Seidel B, Marcinkiewicz M, et al. Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids. J Neurosci. 1997;17:563–575. doi: 10.1523/JNEUROSCI.17-02-00563.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Farooqi IS, Volders K, Stanhope R, et al. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J Clin Endocrinol Metab. 2007;92:3369–3373. doi: 10.1210/jc.2007-0687. [DOI] [PubMed] [Google Scholar]
  7. Gjesing AP, Vestmar MA, Jorgensen T, et al. The effect of PCSK1 variants on waist, waist-hip ratio and glucose metabolism is modified by sex and glucose tolerance status. PLoS One. 2011;6:e23907. doi: 10.1371/journal.pone.0023907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goossens GH, Petersen L, Blaak EE, et al. Several obesity- and nutrient-related gene polymorphisms but not FTO and UCP variants modulate postabsorptive resting energy expenditure and fat-induced thermogenesis in obese individuals: the NUGENOB study. Int J Obes (Lond) 2009;33:669–679. doi: 10.1038/ijo.2009.59. [DOI] [PubMed] [Google Scholar]
  9. Heni M, Haupt A, Schafer SA, et al. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion. BMC Med Genet. 2010;11:86. doi: 10.1186/1471-2350-11-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jackson RS, Creemers JW, Farooqi IS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003;112:1550–1560. doi: 10.1172/JCI18784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16:303–306. doi: 10.1038/ng0797-303. [DOI] [PubMed] [Google Scholar]
  12. Kilpelainen TO, Bingham SA, Khaw KT, Wareham NJ, Loos RJ. Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study. Hum Molec Genet. 2009;18:3496–3501. doi: 10.1093/hmg/ddp280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liu J, Hanley AJ, Young TK, Harris SB, Zinman B. Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes. 2006;30:669–676. doi: 10.1038/sj.ijo.0803179. [DOI] [PubMed] [Google Scholar]
  14. Lloyd DJ, Bohan S, Gekakis N. Obesity, hyperphagia and increased metabolic efficiency in PC1 mutant mice. Hum Mol Genet. 2006;15:1884–1893. doi: 10.1093/hmg/ddl111. [DOI] [PubMed] [Google Scholar]
  15. Mbikay M, Croissandeau G, Sirois F, et al. A targeted deletion/insertion in the mouse Pcsk1 locus is associated with homozygous embryo preimplantation lethality, mutant allele preferential transmission and heterozygous female susceptibility to dietary fat. Dev Biol. 2007;306:584–598. doi: 10.1016/j.ydbio.2007.03.523. [DOI] [PubMed] [Google Scholar]
  16. Mbikay M, Sirois F, Nkongolo KK, Basak A, Chretien M. Effects of rs6234/rs6235 and rs6232/rs6234/rs6235 PCSK1 single-nucleotide polymorphism clusters on proprotein convertase 1/3 biosynthesis and activity. Mol Genet Metab. 2011;104:682–687. doi: 10.1016/j.ymgme.2011.09.027. [DOI] [PubMed] [Google Scholar]
  17. Muller L, Lindberg I. The cell biology of the prohormone convertases PC1 and PC2. Prog Nucleic Ac Res Mol Biol. 1999;63:69–108. doi: 10.1016/S0079-6603(08)60720-5. [DOI] [PubMed] [Google Scholar]
  18. Qi Q, Li H, Loos RJ, et al. Association of PCSK1 rs6234 with obesity and related traits in a Chinese Han population. PLoS One. 2010;5:e10590. doi: 10.1371/journal.pone.0010590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Renstrom F, Payne F, Nordstrom A, et al. Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Molec Genet. 2009;18:1489–1496. doi: 10.1093/hmg/ddp041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rouskas K, Kouvatsi A, Paletas K et al (2011) Common variants in FTO, MC4R, TMEM18, PRL, AIF1, and PCSK1 show evidence of association with adult obesity in the Greek population. Obesity. doi:10.1038/oby.2011.177 [DOI] [PubMed]
  21. Seidah NG, Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 1999;848:45–62. doi: 10.1016/S0006-8993(99)01909-5. [DOI] [PubMed] [Google Scholar]
  22. Sirois F, Gbeha E, Sanni A, et al. Ethnic differences in the frequency of the cardioprotective C679X PCSK9 mutation in a West African population. Genet Testing. 2008;12:377–380. doi: 10.1089/gte.2008.0013. [DOI] [PubMed] [Google Scholar]
  23. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41:25–34. doi: 10.1038/ng.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zhu X, Zhou A, Dey A, et al. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Nat Acad Sci U S A. 2002;99:10293–10298. doi: 10.1073/pnas.162352599. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ESM 1 (27.5KB, doc)

(DOC 27 kb)

ESM 2 (99KB, doc)

(DOC 99 kb)


Articles from Journal of Community Genetics are provided here courtesy of Springer

RESOURCES